Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!

Product Image
Product Description

Increase your productivity to 5 kg+ per day with the FlowSyn™ Maxi from Uniqsis!

The FlowSyn Maxi is a versatile and highly productive continuous flow reactor for high throughput single reactions with two reagents. With a flow rate of up to 80 ml/ min and the option to use Uniqsis’ high capacity (60 ml) coil reactor, the FlowSyn Maxi is the ideal scale-up tool for increasing your output to multi kg per day.

The high resolution FlowSyn user interface quickly guides you through the process of setting up your desired flow chemistry reactions. Once set up, the system automatically runs the experiment and cleans itself at the end of the program cycle. Comprehensive safety features, including automatic pressure regulation and over-pressure shut-down, ensure safe operation at all times.

With its key flowpath components made of stainless steel, the FlowSyn Maxi is a highly robust system capable of operating at 260°C, 1400 psi, and withstanding contact with corrosive fluids such as sulphuric and nitric acid. Other flowpath options (such as Hastelloy® and PTFE) are available for maximum chemical compatibility.

Uniqsis offers extensive “plug and play” options for temperature controlled static mixers and coil reactors, including the FlowSyn 60 ml coil reactor kit specifically designed for scale up.

The high-throughput FlowSyn Maxi can be expanded with the Uniqsis Binary Pump Module (BPM) to provide 4 reagent inputs and with other FlowSyn modules for automated multi-experiment and multi-step combinatorial capability. Optional cooling modules, with cooling capacities down to -88°C, are available for controlling highly exothermic reactions.

If you are looking at improving the output of your flow chemistry experiments, consider the FlowSyn Maxi from Uniqsis. Scale-up has never been easier!

Uniqsis-FlowSyn-Maxi.gif

UniqsisFlowSynMaxiSecImage.gif

Product FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Uniqsis
29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747

Email: info@uniqsis.com



Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!